Understanding the molecular causes behind early onset Parkinson’s
Researchers have identified the molecular causes of early onset Parkinson’s disease, creating a pathway for new treatments.
The average age of Parkinson’s disease onset is...
NHS strike life-saving deal for pembrolizumab
In an exciting announcement, the NHS has revealed it has secured a potentially lifesaving deal for pembrolizumab, a drug tailored to breast cancer.
Pembrolizumab is...
COVID-19 vaccination does not affect nasopharyngeal cancer treatment
The COVID-19 vaccine has been proven not to reduce the efficacy of nasopharyngeal cancer treatment, despite previous concerns.
Drugs that activate the immune system against tumours...
Inflammatory bowel disease is a risk factor for premature birth
A University of Gothenburg study shows that inflammatory bowel disease is a risk factor for preterm birth even when in apparent disease remission.
The findings...
Personalised genetic sequencing can help diagnose rare diseases
Tailoring genetic sequencing to individual patients could double the diagnostic rates of rare diseases, according to researchers from University College London.
The UK Department of...
Substance use disorder leads to worse general health outcomes
According to new research, people with a history of hospitalisation due to substance use disorder experience significantly worse outcomes following the onset of a...
One in five patients missed out on a rheumatoid arthritis diagnosis during COVID
A new study by Kings College London has found that the number of patients receiving their rheumatoid arthritis diagnosis fell by 20% in the...
Inflammatory brain cells could be one of the key causes of schizophrenia
Researchers from the Karolinska Institutet have found that having fewer connections between nerve cells could be one of the key causes of schizophrenia.
The researchers...
Obesity at the time of MS diagnosis linked to greater levels of disability
Being obese at the time of multiple sclerosis (MS) diagnosis has been linked to higher levels of current and subsequent disability, according to research...
A surge in prostate cancer treatments in England
New data from NHS England illuminates a surge in men having prostate cancer treatments compared to one year ago.
NHS figures show that almost 4,000...
A rapid test for antiphospholipid syndrome is under development
Researchers from the University of Geneva have made a discovery which will enable the development of new rapid screening tests for antiphospholipid syndrome.
Antiphospholipid syndrome...
Identifying pancreatic cancer up to three years early
Researchers discover a novel method of identifying pancreatic cancer up to three years early than current diagnoses.
In the largest study of its kind, researchers...
New gene editing technology may treat resistant childhood leukaemia
A team of researchers have engineered donor T-cells to treat childhood leukaemia that is resistant to other therapies.
The Phase I trial, conducted by University...
Dense breast tissue can lead to higher risk of cancer
Researchers from Linköping University have found that there are major biological differences between dense breast tissue and non-dense breast tissue, suggesting that dense breasts...
Social vulnerabilities linked to cardiometabolic risk during pregnancy
A new study has found that social vulnerabilities such as living in poverty were linked to increased cardiometabolic risk during pregnancy.
Preliminary research presented at...
“We must do better, go faster, and strive for more in cardiac care”
Dr Charmaine Griffiths, Chief Executive of the British Heart Foundation discusses the vital steps that need to be taken to ensure cardiac care can...
Retraining the immune system to treat haemophilia A
A study from the University of Bonn (UKB) has discovered an important mechanism that is crucial for improving therapy for Haemophilia A patients.
The most...
Researchers develop new MRI Alzheimer’s test
An exciting MRI Alzheimer’s test by the University of Aberdeen will be trialled for the first time, providing new hope to patients.
A newly developed...
Workplace exposure to harmful substances linked to respiratory conditions
Exposure to gases, fumes, dust, and aromatic solvents used in paints and varnishes in the workplace has been linked to poor lung capacity and...
Improving treatment for head and neck cancer
Researchers from MedUni Vienna and the Christian Doppler Laboratory for Applied Metabolomics have been developing new markers to improve head and neck cancer treatment.
Head...
